Last reviewed · How we verify
Human TH-SC01 Cell Injection — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Human TH-SC01 Cell Injection (Human TH-SC01 Cell Injection) — Jiangsu Topcel-KH Pharmaceutical Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Human TH-SC01 Cell Injection TARGET | Human TH-SC01 Cell Injection | Jiangsu Topcel-KH Pharmaceutical Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Human TH-SC01 Cell Injection CI watch — RSS
- Human TH-SC01 Cell Injection CI watch — Atom
- Human TH-SC01 Cell Injection CI watch — JSON
- Human TH-SC01 Cell Injection alone — RSS
Cite this brief
Drug Landscape (2026). Human TH-SC01 Cell Injection — Competitive Intelligence Brief. https://druglandscape.com/ci/human-th-sc01-cell-injection. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing